PARGY-LAD
From Wikipedia, the free encyclopedia
PARGY-LAD
|
|
Systematic (IUPAC) name | |
(6aR,9R)-N,N-diethyl-7-propynyl-4,6,6a,7,8,9- hexahydroindolo-[4,3-fg]quinoline-9-carboxamide |
|
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C22H25N3O |
Mol. mass | 347.46 g/mol |
Synonyms | PARGY-LAD, 6-propynyl-6-nor-Lysergic acid diethylamide |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | hepatic |
Half life | ? |
Excretion | renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | Oral |
PARGY-LAD, also known as 6-propynyl-6-nor-lysergic acid diethylamide is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PARGY-LAD is a hallucinogenic drug similar to LSD, but is slightly less potent than LSD with a dose of 160 micrograms producing only mild effects, and 500 micrograms required for full activity.
|